Transdermal Semaglutide Administration in Mice: Reduces Body Weight by Suppressing Appetite and Enhancing Metabolic Rate.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Transdermal Semaglutide Administration in Mice: Reduces Body Weight by Suppressing Appetite and Enhancing Metabolic Rate.
- Published In:
- Biology, 14(5) (2025)
- Authors:
- Li, Wenjing(3), Cai, Ruilin, Yin, Binxin, Zhou, Yingying, Dong, Xinyuan, Li, Wenting, Wen, Jing
- Database ID:
- RPEP-12103
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-12103APA
Li, Wenjing; Cai, Ruilin; Yin, Binxin; Zhou, Yingying; Dong, Xinyuan; Li, Wenting; Wen, Jing. (2025). Transdermal Semaglutide Administration in Mice: Reduces Body Weight by Suppressing Appetite and Enhancing Metabolic Rate.. Biology, 14(5). https://doi.org/10.3390/biology14050575
MLA
Li, Wenjing, et al. "Transdermal Semaglutide Administration in Mice: Reduces Body Weight by Suppressing Appetite and Enhancing Metabolic Rate.." Biology, 2025. https://doi.org/10.3390/biology14050575
RethinkPeptides
RethinkPeptides Research Database. "Transdermal Semaglutide Administration in Mice: Reduces Body..." RPEP-12103. Retrieved from https://rethinkpeptides.com/research/li-2025-transdermal-semaglutide-administration-in
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.